Bausch Health Companies Inc. Business Acquisition, Equity Interest Issued or Issuable, Value Assigned
Bausch Health Companies Inc. (BHC) had Business Acquisition, Equity Interest Issued or Issuable, Value Assigned of $3.88 billion as of 2010-12-31, per its 10-K filed 2013-02-28.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned · last filed 2013-02-28
- 2010-12-31: Business Acquisition, Equity Interest Issued or Issuable, Value Assigned $3.88B; Business Acquisition, Equity Interest Issued or Issuable, Value Assigned as first filed -$3.88B.
- 2010-09-30: Business Acquisition, Equity Interest Issued or Issuable, Value Assigned -$3.88B; Business Acquisition, Equity Interest Issued or Issuable, Value Assigned as first filed $3.88B.
| Period end | Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | Business Acquisition, Equity Interest Issued or Issuable, Value Assigned as first filed |
|---|---|---|
| 2010-12-31 | $3.88B 10-K · filed 2013-02-28 | -$3.88B 10-K · filed 2011-02-28 |
| 2010-09-30 | -$3.88B 10-Q · filed 2011-11-04 | $3.88B 10-Q · filed 2010-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |